Clean Yield Group Has $198,000 Stock Holdings in Danaher Corporation $DHR

Clean Yield Group lifted its stake in shares of Danaher Corporation (NYSE:DHR) by 7.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,004 shares of the conglomerate’s stock after purchasing an additional 72 shares during the period. Clean Yield Group’s holdings in Danaher were worth $198,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. Nuveen LLC acquired a new stake in shares of Danaher during the first quarter worth $833,941,000. Invesco Ltd. raised its position in shares of Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the period. Baird Financial Group Inc. raised its position in shares of Danaher by 290.6% during the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after purchasing an additional 1,072,617 shares during the period. Generation Investment Management LLP raised its position in Danaher by 33.2% during the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock valued at $651,515,000 after buying an additional 791,662 shares during the period. Finally, Parnassus Investments LLC raised its position in Danaher by 23.3% during the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after buying an additional 722,636 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Evercore ISI dropped their price target on Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft dropped their price target on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Robert W. Baird upped their price target on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Finally, Bank of America dropped their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.91.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 11.20% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $184.97 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.59. The stock’s 50-day moving average is $199.44 and its two-hundred day moving average is $197.48. The firm has a market cap of $132.45 billion, a P/E ratio of 39.36, a PEG ratio of 2.63 and a beta of 0.75.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s revenue was up 3.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.